Search - tctmd.com

Displaying 141 - 160 of 762

Sort: Relevancy | Date

News Conference News ESC 2023

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Michael O'Riordan

September 01, 2023

News Daily News

TCTMD’s Michael O’Riordan Wins Digital Health Award

Shelley Wood

August 22, 2023

News Daily News

Statin Therapy Still Lacking for Many US Patients With ASCVD

L.A. McKeown

August 07, 2023

News Daily News

Vegetarian Diets May Curb Cardiometabolic Risk: Meta-analysis

Caitlin E. Cox

August 01, 2023

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

News Daily News

More Data Show Redlining’s Lasting Impact on CVD Risk

L.A. McKeown

July 14, 2023

News Daily News

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Michael O'Riordan

July 11, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Daily News

Keto Diet for Heart Failure? What Clinicians, Patients Need to Know

Caitlin E. Cox

July 06, 2023

News Daily News

LDL Control Remains Poor in CAD Patients: NHANES

Michael O'Riordan

July 05, 2023

News Daily News

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

Michael O'Riordan

June 30, 2023

News Conference News ADA 2023

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

L.A. McKeown

June 28, 2023

News Conference News ADA 2023

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Michael O'Riordan

June 28, 2023

News Daily News

FDA Approves Colchicine for Decreasing CV Events

Caitlin E. Cox

June 20, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Daily News

Lipid Panels in Standard Precath Blood Draws? Researchers Say It’s Time

Todd Neale

June 13, 2023

News Conference News EAS 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Michael O'Riordan

May 29, 2023

News Conference News ESOC 2023

ECST-2: No Benefit of Carotid Revascularization on Top of Best Medical Therapy

Todd Neale

May 26, 2023

News Conference News EAS 2023

Multipronged Outreach to Families Can Boost FH Cascade Screening: IMPACT-FH

Michael O'Riordan

May 26, 2023

News Conference News EAS 2023

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

Michael O'Riordan

May 24, 2023

Advertisement

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

TCTMD’s Michael O’Riordan Wins Digital Health Award

Statin Therapy Still Lacking for Many US Patients With ASCVD

Vegetarian Diets May Curb Cardiometabolic Risk: Meta-analysis

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

More Data Show Redlining’s Lasting Impact on CVD Risk

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Keto Diet for Heart Failure? What Clinicians, Patients Need to Know

LDL Control Remains Poor in CAD Patients: NHANES

Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

FDA Approves Colchicine for Decreasing CV Events

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Lipid Panels in Standard Precath Blood Draws? Researchers Say It’s Time

With New LDL Goalposts in FH, Combo Therapy Must Start Early

ECST-2: No Benefit of Carotid Revascularization on Top of Best Medical Therapy

Multipronged Outreach to Families Can Boost FH Cascade Screening: IMPACT-FH

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content